ECX — Epigenomics AG Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Epigenomics AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	GAS	GAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	10.9	4.47	23	7.8	2.1
Net Total Accounts Receivable
Net Total Receivables	0.473	0.401	0.173	0.051	0.299
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	12.1	5.47	23.7	8.12	2.49
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.53	1.18	0.891	0.568	0.003
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	14	6.8	24.7	14	12.8
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3.62	2.44	2.14	0.657	0.482
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	4.36	2.93	2.54	14	12.8
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	9.63	3.86	22.1	0	0
Total Liabilities & Shareholders' Equity	14	6.8	24.7	14	12.8
Total Common Shares Outstanding